|
|
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Basic information |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Usage And Synthesis |
| Description | A novel combination of triterpenoids includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS), the composition is suitable for the treatment or prophylaxis of colon cancer, hepatic cancer, breast cancer, lung cancer or leukemia. Ganoderic acid S and Mf induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells. | | Uses | Ganoderic acid S1 (compound 4) is a natural product that can be found in ganoderma lucidum[1]. | | Definition | ChEBI: Ganoderic acid S is a triterpenoid. | | References | [1] Morigiwa A, et al. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull (Tokyo). 1986 Jul;34(7):3025-8. DOI:10.1248/cpb.34.3025 |
| | (24E)-3-Oxo-5α-lanosta-7,9(11),24-trien-26-oic acid Preparation Products And Raw materials |
|